河南省公立医疗机构联盟2023年神经介入类医用耗材首次集采采用全品类现场议价谈判机制,2024年接续采购选择“外省价格联动”为主的温和政策,融合京津冀、江苏、安徽等省份集采成果,在保障临床供应的同时有效应对价格洼地的挑战。本文从背景、规则、成果、潜在问题与建议等多个维度展开深度解析,针对神经介入手术高风险、高精度器械需求及进口品牌主导的市场现状,河南省公立医院联盟集采通过设置差异化价格机制、合理分组等政策,旨在实现耗材降价、减轻患者负担的同时,兼顾临床使用习惯,并为后期高值医用耗材集采政策提出优化建议。

In 2023, the first centralized procurement for neurointerventional medical consumables by the Henan Province Public Medical Institution Alliance adopted an on-site, full-category negotiation mechanism. In 2024, the subsequent procurement chose a moderate policy of "price linkage from other provinces" as the main approach, integrating the results of centralized procurement from Beijing City,Tianjin City, Hebei Province, Jiangsu Province, and Anhui Province, effectively addressing the challenges of price troughs while ensuring clinical supply. This article conducts in-depth analysis from multiple dimensions such as background, rules, achievements, potential problems, and suggestions. In response to the high-risk and high-precision instrument demand of neurointerventional surgery, as well as the market situation dominated by imported brands, the Henan Province Alliance Procurement adopts policies such as setting differentiated pricing mechanisms and reasonable grouping to reduce consumables price and patient burden, while also taking into account clinical usage habits. Furthermore, the study offers optimization suggestions for future procurement policies for high-value medical consumables.